Nifedipine and Bay K 8644 Induce an Increase of [Ca2+] i and Nitric Oxide in Endothelial Cells
- 1 September 1999
- journal article
- other
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 4 (3) , 175-181
- https://doi.org/10.1177/107424849900400307
Abstract
Background: The dihydropyridine-induced vasorelaxation is partly dependent on the endothelium, which does not express L-type calcium channels. Because nitric oxide (NO) is one of the most important endothelium-derived vasorelaxing factors, we investigated how the calcium antagonist nifedipine and the calcium agonist Bay K 8644 modulate intracellu lar calcium and NO formation in porcine endothelial cells.Methods and Results: NO formation of porcine aortic endothelial cell cultures and of native endothelium of intact porcine coronary arteries was measured with an electrochemi cal electrode, and the intracellular concentration of Ca2+[Ca2+]iwas evaluated using the Fura-2 technique. Nifedipine induced a concentration-dependent [0.01-1 μmol/L] increase in [Ca2+]iand NO formation in cultured porcine aortic endothelial cells, and moreover a dose- dependent NO formation in native endothelial cells from intact porcine coronary arteries, which was higher than in cultured cells. This effect was inhibited by N-nitro-L-arginine, a spe cific NO synthase inhibitor. Bay K 8644 caused a [Ca2+]iincrease and NO release in cul tured cells, too, although to a lesser extent. Nifedipine-induced and Bay K 8644-induced [Ca2+]irise could be blocked by removal of extracellular calcium, indicating that a calcium influx may be involved.Conclusions: The calcium antagonist nifedipine as well as the calcium agonist Bay K 8644 cause an increase of [Ca2+]iand NO in porcine endothelium. Therefore, these effects seem to be related to the dihydropyridines as a substance class, which may explain the endothe lial component in dihydropyridine-induced vasorelaxation.Keywords
This publication has 38 references indexed in Scilit:
- Current status of calcium channel blockersCurrent Problems in Cardiology, 1994
- Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.Hypertension, 1994
- Comparative effects of the Dihydropyridine-type calcium-agonists (−)-S-Bay K 8644, (±)-Bay-W 5035 and (±)-Bay-T 5006 on human platelet aggregabilityGeneral Pharmacology: The Vascular System, 1994
- Continuous Monitoring of Nitric Oxide Release from Human Umbilical Vein Endothelial CellsBiochemical and Biophysical Research Communications, 1993
- Intracellular calcium, currents, and stimulus-response coupling in endothelial cells.Hypertension, 1993
- Intracellular calcium ‘signatures’ evoked by different agonists in isolated bovine aortic endothelial cellsCell Calcium, 1992
- Reduced responses of nitrendipine in PGF2α-precontracted porcine isolated arteries after pretreatment with methylene blueBasic Research in Cardiology, 1990
- Influence of nifedipine on experimental arteriosclerosisCardiovascular Drugs and Therapy, 1990
- Endothelial control of vascular tone in large and small coronary arteriesJournal of the American College of Cardiology, 1990
- Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cellsBiochemical and Biophysical Research Communications, 1988